{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T04:09:04Z","timestamp":1750392544285,"version":"3.41.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03817-6","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T08:47:27Z","timestamp":1734425247000},"page":"2769-2777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Axillary lymph node management strategies in cN\u2009+\u2009breast cancer patients after neoadjuvant chemotherapy"],"prefix":"10.1007","volume":"27","author":[{"given":"Min","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9236-3014","authenticated-orcid":false,"given":"Ling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"issue":"6","key":"3817_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrclinonc.2015.63","volume":"12","author":"TA King","year":"2015","unstructured":"King TA, Morrow M. Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nat Rev Clin Oncol. 2015;12(6):335\u201343.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"3817_CR2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","volume":"250","author":"KK Hunt","year":"2009","unstructured":"Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg. 2009;250(4):558\u201366.","journal-title":"Ann Surg"},{"issue":"2","key":"3817_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","volume":"173","author":"JM Classe","year":"2019","unstructured":"Classe JM, Loaec C, Gimbergues P, Alran S, de Lara CT, Dupre PF, et al. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat. 2019;173(2):343\u201352.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"3817_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318.","journal-title":"Lancet Oncol"},{"issue":"12","key":"3817_CR5","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27. J Clin Oncol. 2005;23(12):2694\u2013702.","journal-title":"J Clin Oncol"},{"issue":"14","key":"3817_CR6","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361.","journal-title":"JAMA"},{"key":"3817_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-02953-1","author":"JC Vazquez","year":"2022","unstructured":"Vazquez JC, Pinero A, De Castro FJ, Lluch A, Martin M, Barnadas A, et al. The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic review. Clin Transl Oncol. 2022. https:\/\/doi.org\/10.1007\/s12094-022-02953-1.","journal-title":"Clin Transl Oncol"},{"key":"3817_CR8","doi-asserted-by":"publisher","first-page":"1507881","DOI":"10.1155\/2022\/1507881","volume":"2022","author":"S Aragon-Sanchez","year":"2022","unstructured":"Aragon-Sanchez S, Oliver-Perez MR, Madariaga A, Tabuenca MJ, Martinez M, Galindo A, et al. Accuracy and limitations of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive nodes. Breast J. 2022;2022:1507881.","journal-title":"Breast J"},{"issue":"4","key":"3817_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.clbc.2016.02.009","volume":"16","author":"K Enokido","year":"2016","unstructured":"Enokido K, Watanabe C, Nakamura S, Ogiya A, Osako T, Akiyama F, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with an initial diagnosis of cytology-proven lymph node-positive breast cancer. Clin Breast Cancer. 2016;16(4):299\u2013304.","journal-title":"Clin Breast Cancer"},{"key":"3817_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.breast.2021.07.015","volume":"59","author":"S Cao","year":"2021","unstructured":"Cao S, Liu X, Cui J, Liu X, Zhong J, Yang Z, et al. Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: an up-to-date meta-analysis of 3578 patients. Breast. 2021;59:256\u201369.","journal-title":"Breast"},{"issue":"1","key":"3817_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10549-017-4164-1","volume":"163","author":"LH Zetterlund","year":"2017","unstructured":"Zetterlund LH, Frisell J, Zouzos A, Axelsson R, Hatschek T, de Boniface J, et al. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer. Breast Cancer Res Treat. 2017;163(1):103\u201310.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3817_CR12","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1245\/s10434-021-11297-z","volume":"29","author":"S-Q Lin","year":"2022","unstructured":"Lin S-Q, Vo N-P, Yen Y-C, Tam K-W. Outcomes of sentinel node biopsy for women with breast cancer after neoadjuvant therapy: systematic review and meta-analysis of real-world data. Ann Surg Oncol. 2022;29(5):3038\u201349.","journal-title":"Ann Surg Oncol"},{"key":"3817_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.amsu.2020.09.030","volume":"59","author":"P Chirappapha","year":"2020","unstructured":"Chirappapha P, Chatmongkonwat T, Lertsithichai P, Pipatsakulroj W, Sritara C, Sukarayothin T. Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green: prospective cohort study. Ann Med Surg (Lond). 2020;59:156\u201360.","journal-title":"Ann Med Surg (Lond)"},{"issue":"10","key":"3817_CR14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072\u20138.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3817_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.surge.2021.01.013","volume":"19","author":"M Alarcon","year":"2021","unstructured":"Alarcon M, Buch E, Julve A, Hernandorena M, Tajahuerce M, Rodriguez H, et al. Sentinel lymph node BIOPSY after neoadjuvant therapy in breast cancer patients with lymph node involvement at diagnosis. Could wire localization of clipped node improve our results? Surgeon. 2021;19(6):344\u201350.","journal-title":"Surgeon"},{"issue":"2","key":"3817_CR16","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s00268-017-4171-8","volume":"42","author":"EY Kim","year":"2018","unstructured":"Kim EY, Byon WS, Lee KH, Yun JS, Park YL, Park CH, et al. Feasibility of preoperative axillary lymph node marking with a clip in breast cancer patients before neoadjuvant chemotherapy: a preliminary study. World J Surg. 2018;42(2):582\u20139.","journal-title":"World J Surg"},{"issue":"3","key":"3817_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"J-F Boileau","year":"2015","unstructured":"Boileau J-F, Poirier B, Basik M, Holloway CMB, Gaboury L, Sideris L, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258\u201364.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3817_CR18","doi-asserted-by":"publisher","first-page":"e105316","DOI":"10.1371\/journal.pone.0105316","volume":"9","author":"J-F Fu","year":"2014","unstructured":"Fu J-F, Chen H-L, Yang J, Yi C-H, Zheng S. Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis. PLoS ONE. 2014;9(9):e105316.","journal-title":"PLoS ONE"},{"issue":"5","key":"3817_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","volume":"27","author":"J-M Classe","year":"2009","unstructured":"Classe J-M, Bordes V, Campion L, Mignotte H, Dravet F, Leveque J, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of ganglion sentinelle et chimiotherapie neoadjuvante, a french prospective multicentric study. J Clin Oncol. 2009;27(5):726\u201332.","journal-title":"J Clin Oncol"},{"issue":"9938","key":"3817_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164\u201372.","journal-title":"Lancet"},{"issue":"4","key":"3817_CR21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ejso.2020.10.014","volume":"47","author":"S Kahler-Ribeiro-fontana","year":"2021","unstructured":"Kahler-Ribeiro-fontana S, Pagan E, Magnoni F, Vicini E, Morigi C, Corso G, et al. Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up. Eur J Surg Oncol. 2021;47(4):804\u201312.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"3817_CR22","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1245\/s10434-020-08900-0","volume":"27","author":"MA Piltin","year":"2020","unstructured":"Piltin MA, Hoskin TL, Day CN, Davis J, Boughey JC. Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer. Ann Surg Oncol. 2020;27(12):4795\u2013801.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"3817_CR23","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1245\/s10434-020-09211-0","volume":"28","author":"SM Wong","year":"2021","unstructured":"Wong SM, Basik M, Florianova L, Margolese R, Dumitra S, Muanza T, et al. Oncologic safety of sentinel lymph node biopsy alone after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol. 2021;28(5):2621\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"3817_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4048\/jbc.2021.24.e48","volume":"24","author":"H Kim","year":"2021","unstructured":"Kim H, Han J, Kim SY, Lee ES, Kang HS, Lee S, et al. Sentinel lymph node biopsy in breast cancer patients with pathological complete response in the axillary lymph node after neoadjuvant chemotherapy. J Breast Cancer. 2021;24(6):531\u201341.","journal-title":"J Breast Cancer"},{"issue":"10","key":"3817_CR25","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.ejso.2021.06.024","volume":"47","author":"N Cabio\u011flu","year":"2021","unstructured":"Cabio\u011flu N, Karanlik H, Yildirim N, M\u00fcsl\u00fcmano\u011flu M, \u00c7akmak Karadeniz G, Trabulus Can D, et al. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish multicentric NEOSENTI-TURK MF-18\u201302-study. Eur J Surg Oncol. 2021;47(10):2506\u201314.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"3817_CR26","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","volume":"7","author":"AV Barrio","year":"2021","unstructured":"Barrio AV, Montagna G, Mamtani A, Sevilimedu V, Edelweiss M, Capko D, et al. Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy-a rare event. JAMA Oncol. 2021;7(12):1851\u20135.","journal-title":"JAMA Oncol"},{"issue":"2","key":"3817_CR27","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1245\/s10434-020-08928-2","volume":"28","author":"MF Almahariq","year":"2021","unstructured":"Almahariq MF, Levitin R, Quinn TJ, Chen PY, Dekhne N, Kiran S, et al. Omission of axillary lymph node dissection is associated with inferior survival in breast cancer patients with residual n1 nodal disease following neoadjuvant chemotherapy. Ann Surg Oncol. 2021;28(2):930\u201340.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3817_CR28","doi-asserted-by":"publisher","first-page":"9056","DOI":"10.1038\/s41598-021-88442-x","volume":"11","author":"JW Chun","year":"2021","unstructured":"Chun JW, Kim J, Chung IY, Ko BS, Kim HJ, Lee JW, et al. Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy. Sci Rep. 2021;11(1):9056.","journal-title":"Sci Rep"},{"issue":"11","key":"3817_CR29","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1245\/s10434-019-07517-2","volume":"26","author":"SM Wong","year":"2019","unstructured":"Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K, et al. Prognostic significance of residual axillary nodal micrometastases and isolated tumor cells after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol. 2019;26(11):3502\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3817_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10549-017-4157-0","volume":"163","author":"TJA van Nijnatten","year":"2017","unstructured":"van Nijnatten TJA, Simons JM, Moossdorff M, de Munck L, Lobbes MBI, van der Pol CC, et al. Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases. Breast Cancer Res Treat. 2017;163(1):159\u201366.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3817_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","volume":"261","author":"M Donker","year":"2015","unstructured":"Donker M, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261(2):378\u201382.","journal-title":"Ann Surg"},{"issue":"1","key":"3817_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-022-06545-z","volume":"193","author":"AA van Loevezijn","year":"2022","unstructured":"van Loevezijn AA, van der Noordaa MEM, Stokkel MPM, van Werkhoven ED, Groen EJ, Loo CE, et al. Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol. Breast Cancer Res Treat. 2022;193(1):37\u201348.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"3817_CR33","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","volume":"263","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0\u2013T4, N1\u2013N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance). Ann Surg. 2016;263(4):802\u20137.","journal-title":"Ann Surg"},{"issue":"9","key":"3817_CR34","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.ejso.2018.05.035","volume":"44","author":"S Hartmann","year":"2018","unstructured":"Hartmann S, Reimer T, Gerber B, Stubert J, Stengel B, Stachs A. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy. Eur J Surg Oncol. 2018;44(9):1307\u201311.","journal-title":"Eur J Surg Oncol"},{"issue":"13","key":"3817_CR35","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1245\/s10434-015-4527-y","volume":"22","author":"D Plecha","year":"2015","unstructured":"Plecha D, Bai S, Patterson H, Thompson C, Shenk R. Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes. Ann Surg Oncol. 2015;22(13):4241\u20136.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3817_CR36","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1245\/s10434-020-08925-5","volume":"28","author":"A Garcia-Novoa","year":"2021","unstructured":"Garcia-Novoa A, Acea-Nebril B, Diaz Carballada C, Bouzon Alejandro A, Conde C, Cereijo Garea C, et al. Combining wire localization of clipped nodes with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer: preliminary results from a prospective study. Ann Surg Oncol. 2021;28(2):958\u201367.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3817_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.rcl.2016.12.012","volume":"55","author":"MK Hayes","year":"2017","unstructured":"Hayes MK. Update on preoperative breast localization. Radiol Clin North Am. 2017;55(3):591\u2013603.","journal-title":"Radiol Clin North Am"},{"issue":"3","key":"3817_CR38","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/bjs\/znaa083","volume":"108","author":"S Hartmann","year":"2021","unstructured":"Hartmann S, Kuhn T, de Boniface J, Stachs A, Winckelmann A, Frisell J, et al. Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial. Br J Surg. 2021;108(3):302\u20137.","journal-title":"Br J Surg"},{"issue":"6","key":"3817_CR39","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.ejso.2019.11.501","volume":"46","author":"TM Allweis","year":"2020","unstructured":"Allweis TM, Menes T, Rotbart N, Rapson Y, Cernik H, Bokov I, et al. Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery. Eur J Surg Oncol. 2020;46(6):1041\u20135.","journal-title":"Eur J Surg Oncol"},{"key":"3817_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znac311","author":"L Zhang","year":"2022","unstructured":"Zhang L, Cheng M, Lin Y, Zhang J, Shen B, Chen Y, et al. Ultrasound-assisted carbon nanoparticle suspension mapping versus dual tracer-guided sentinel lymph node biopsy in patients with early breast cancer (ultraCars): phase III randomized clinical trial. Br J Surg. 2022. https:\/\/doi.org\/10.1093\/bjs\/znac311.","journal-title":"Br J Surg"},{"issue":"2","key":"3817_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1245\/s10434-014-4034-6","volume":"22","author":"N Choy","year":"2015","unstructured":"Choy N, Lipson J, Porter C, Ozawa M, Kieryn A, Pal S, et al. Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients. Ann Surg Oncol. 2015;22(2):377\u201382.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"3817_CR42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.acra.2018.07.002","volume":"26","author":"RW Woods","year":"2019","unstructured":"Woods RW, Camp MS, Durr NJ, Harvey SC. A review of options for localization of axillary lymph nodes in the treatment of invasive breast cancer. Acad Radiol. 2019;26(6):805\u201319.","journal-title":"Acad Radiol"},{"issue":"9","key":"3817_CR43","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/bjs\/znac217","volume":"109","author":"ML Gasparri","year":"2022","unstructured":"Gasparri ML, de Boniface J, Poortmans P, Gentilini OD, Kaidar-Person O, Banys-Paluchowski M, et al. Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey. Br J Surg. 2022;109(9):857\u201363.","journal-title":"Br J Surg"},{"key":"3817_CR44","doi-asserted-by":"publisher","first-page":"101823","DOI":"10.1016\/j.suronc.2022.101823","volume":"44","author":"S Arag\u00f3n-S\u00e1nchez","year":"2022","unstructured":"Arag\u00f3n-S\u00e1nchez S, Ciruelos-Gil E, L\u00f3pez-Mar\u00edn L, Galindo A, Tabuenca-Mateos MJ, Jim\u00e9nez-Arranz S, et al. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer. Surg Oncol. 2022;44:101823.","journal-title":"Surg Oncol"},{"issue":"5","key":"3817_CR45","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1097\/SLA.0000000000004572","volume":"276","author":"S Kuemmel","year":"2022","unstructured":"Kuemmel S, Heil J, Rueland A, Seiberling C, Harrach H, Schindowski D, et al. A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients. Ann Surg. 2022;276(5):e553\u201362.","journal-title":"Ann Surg"},{"key":"3817_CR46","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2022.3907","author":"JM Simons","year":"2022","unstructured":"Simons JM, van Nijnatten TJA, van der Pol CC, van Diest PJ, Jager A, van Klaveren D, et al. Diagnostic Accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer. JAMA Surg. 2022. https:\/\/doi.org\/10.1001\/jamasurg.2022.3907.","journal-title":"JAMA Surg"},{"issue":"9","key":"3817_CR47","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1055\/a-1889-7883","volume":"82","author":"S Hartmann","year":"2022","unstructured":"Hartmann S, Kuhn T, Hauptmann M, Stickeler E, Thill M, Lux MP, et al. Axillary staging after neoadjuvant chemotherapy for initially node-positive breast carcinoma in Germany: initial data from the AXSANA study. Geburtshilfe Frauenheilkd. 2022;82(9):932\u201340.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"24","key":"3817_CR48","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1200\/JCO.2006.08.8013","volume":"25","author":"JLB Bevilacqua","year":"2007","unstructured":"Bevilacqua JLB, Kattan MW, Fey JV, Cody HS, Borgen PI, van Zee KJ. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 2007;25(24):3670\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3817_CR49","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10549-012-2219-x","volume":"135","author":"J-Y Chen","year":"2012","unstructured":"Chen J-Y, Chen J-J, Yang B-L, Liu Z-B, Huang X-Y, Liu G-Y, et al. Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram. Breast Cancer Res Treat. 2012;135(3):839\u201348.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3817_CR50","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1159\/000338844","volume":"7","author":"L Yeniay","year":"2012","unstructured":"Yeniay L, Carti E, Karaca C, Zekioglu O, Yararbas U, Yilmaz R, et al. A new and simple predictive formula for non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes, and validation of 3 different nomograms in Turkish breast cancer patients. Breast Care (Basel, Switzerland). 2012;7(5):397\u2013402.","journal-title":"Breast Care (Basel, Switzerland)"},{"issue":"6","key":"3817_CR51","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1524-4741.2007.00507.x","volume":"13","author":"N Coombs","year":"2007","unstructured":"Coombs N, Chen W, Taylor R, Boyages J. A decision tool for predicting sentinel node accuracy from breast tumor size and grade. Breast J. 2007;13(6):593\u20138.","journal-title":"Breast J"},{"key":"3817_CR52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.breast.2018.05.011","volume":"41","author":"A Elmadahm","year":"2018","unstructured":"Elmadahm A, Lord SJ, Hudson HM, Lee CK, Buizen L, Farshid G, et al. Performance of four published risk models to predict sentinel lymph-node involvement in Australian women with early breast cancer. Breast. 2018;41:82\u20138.","journal-title":"Breast"},{"issue":"7","key":"3817_CR53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00066-018-1270-x","volume":"194","author":"D Krug","year":"2018","unstructured":"Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, et al. Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer\u202f: a systematic review. Strahlenther Onkol. 2018;194(7):607\u201318.","journal-title":"Strahlenther Onkol"},{"issue":"32","key":"3817_CR54","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1200\/JCO.2011.40.8369","volume":"30","author":"EP Mamounas","year":"2012","unstructured":"Mamounas EP, Anderson SJ, Dignam JJ, Bear HD, Julian TB, Geyer CE, et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of national surgical adjuvant breast and bowel project B-18 and B-27. J Clin Oncol. 2012;30(32):3960\u20136.","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03817-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03817-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T16:02:02Z","timestamp":1750348922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03817-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03817-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}